Pricing Log in Create free account

Disc Medicine, Inc. (IRON) vs Parabilis Medicines, Inc. (PBLS)

Disc Medicine, Inc. and Parabilis Medicines, Inc. are both Biotechnology companies. Disc Medicine, Inc. and Parabilis Medicines, Inc. are of similar size ($3.5B and $3.4B). Across the 9 metrics below, Parabilis Medicines, Inc. leads on 6 and Disc Medicine, Inc. on 3.

Valuation

Metric IRON PBLS Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 4.74 0.77 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 1.79 0.65
EV/Sales n/m n/m 8.98
Earnings yield (8.33%) (297.78%) (34.89%)
Free cash flow yield (6.50%) (14.78%) (24.52%)

Profitability

Metric IRON PBLS Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (39.08%) 0.00% (50.12%)
Return on assets (35.12%) 0.00% (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IRON PBLS Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (51.77%) (10.69%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IRON PBLS Biotechnology median
Debt to equity 0.09 0.01 0.00
Current ratio 24.14 17.91 4.89
Net debt to EBITDA 3.12 0.09 1.01

Dividend

Metric IRON PBLS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IRON PBLS Biotechnology median
Market cap 3.48b 3.44b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack